TEM

Handel nachbörslich: 61.08 -0.29 -0.47%

Tempus Ai Inc (TEM)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Tempus Ai Inc Stock (TEM) Company Profile

Tempus Ai Inc

Healthcare (1153)

800-976-5448

600 WEST CHICAGO AVENUE, CHICAGO

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TEM's Discussions on Twitter

Vergleichen Sie TEM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TEM Tempus Ai Inc	61.37	9.87B	640.44M	-743.28M	-206.93M	-11.29
VEEV Veeva Systems Inc	237.05	38.54B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	59.19	11.13B	516.85M	174.11M	217.38M	0.87
HQY Healthequity Inc	90.40	7.83B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	40.01	7.04B	906.14M	-52.62M	89.62M	-0.3621

Tempus Ai Inc Stock (TEM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-21	Eingeleitet	BTIG Research	Buy
2025-02-25	Herabstufung	JP Morgan	Overweight → Neutral
2025-02-12	Herabstufung	William Blair	Outperform → Mkt Perform
2025-02-05	Fortgesetzt	TD Cowen	Buy
2024-12-13	Eingeleitet	Wolfe Research	Outperform
2024-12-09	Eingeleitet	Guggenheim	Buy
2024-11-11	Herabstufung	Stifel	Buy → Hold
2024-10-02	Herabstufung	BofA Securities	Buy → Neutral
2024-08-12	Eingeleitet	Piper Sandler	Neutral
2024-07-09	Eingeleitet	BofA Securities	Buy
2024-07-09	Eingeleitet	JP Morgan	Overweight
2024-07-09	Eingeleitet	Longbow	Buy
2024-07-09	Eingeleitet	Loop Capital	Buy
2024-07-09	Eingeleitet	Morgan Stanley	Overweight
2024-07-09	Eingeleitet	Needham	Buy
2024-07-09	Eingeleitet	Stifel	Buy
2024-07-09	Eingeleitet	TD Cowen	Buy
2024-07-09	Eingeleitet	William Blair	Outperform

Alle ansehen

Tempus Ai Inc Aktie (TEM) Neueste Nachrichten

Finanzdaten der Tempus Ai Inc-Aktie (TEM)

Tempus Ai Inc (TEM)

Tempus Ai Inc Stock (TEM) Company Profile

Vergleichen Sie TEM mit anderen Aktien

Tempus Ai Inc Stock (TEM) Upgrades & Downgrades

Tempus Ai Inc Aktie (TEM) Neueste Nachrichten

Tempus AI Reports Strong Growth and Strategic Partnerships in Earnings Call - MSN

11 Best Performing Healthcare Stocks to Buy Now - Insider Monkey

Jim Cramer Says Stay Away from This Nancy Pelosi Stock - MSN

These AI Stocks Posted Robust Results: Time to Buy? - The Globe and Mail

The Tempus AI, Inc. (NASDAQ:TEM) First-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st

Tempus AI Stock: Time to Double Down or Cut and Run? - MSN

Morgan Stanley raises Tempus AI price target to $65 from $60 - Investing.com Australia

Tempus AI COO Ryan Fukushima Sells 20,000 Shares - TradingView

Why Tempus AI, Inc. (TEM) Skyrocketed On Wednesday - Insider Monkey

Why These 10 Stocks Soared Today - Insider Monkey

Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals - Benzinga

Tempus AI price target raised to $65 from $60 at BTIG - TipRanks

Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032 | DelveInsight - GlobeNewswire Inc.

U.S. STOCKS ON THE MOVE-Bio-Techne, Johnson Controls, Tempus AI - TradingView

What’s Next For Tempus AI Stock? - Forbes

Tempus AI, Inc. (TEM): Among Most Popular Stocks on Robinhood in 2025 - Insider Monkey

Cathie Wood-Backed Tempus AI Says Pharma Contracts Solid Despite Biotech Funding Challenges, Tariff Pressures - Benzinga

Tempus AI Strikes $200M Deal With AstraZeneca, Pathos To Build World's Largest Oncology Model - Benzinga

Tempus AI raises revenue guidance to $1.25B for 2025, supported by new $200M AstraZeneca deal - MSN

Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Tempus: Q1 Earnings Snapshot - MySA

Earnings call transcript: Tempus AI Q1 2025: Revenue Surges, Stock Dips - Investing.com India

Tempus AI Inc Reports Q1 2025 Revenue of $255.7 Million and Net Loss of $68 Million - GuruFocus

On heels of big data deals, Tempus AI touts robust revenue - Crain's Chicago Business

Tempus AI beats Q1 expectations, raises 2025 outlook; shares dip 2.3% - Investing.com Nigeria

Tempus AI Q1 2025 slides: revenue surges 75%, approaching EBITDA profitability - Investing.com India

Tempus AI Q1 Non-GAAP Loss Narrows; Revenue Rises; Slightly Ups Full Year Guidance - marketscreener.com

Tempus AI reports Q1 adjusted EPS (24c), consensus (27c) - TipRanks

Earnings Flash (TEM) Tempus AI Reports Q1 Revenue $255.7M, vs. FactSet Est of $248.1M - marketscreener.com

Tempus Reports First Quarter 2025 Results - Bluefield Daily Telegraph

Tempus AI Stock Dips as Earnings on Deck (NASDAQ: TEM) – What To Expect - AskTraders.com

Tempus selects TIME Network for Phase I clinical trials - MSN

TEMPUS (Nasdaq: TEM) Earnings: Live Coverage And What to Expect - AOL.com

tempus AI Inc Class A call volume above normal and directionally bullish - TipRanks

Tempus AI (Nasdaq: TEM) Earnings: Live Coverage And What to Expect - 24/7 Wall St.

Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. - AOL.com

Jim Cramer Warns on Tempus AI (TEM): “Diagnostics With no Dough? I’m Out” - Insider Monkey

AI Healthcare Boom Gains Speed as Regulators and Innovators Align - The Globe and Mail

Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry - Business Wire

Tempus AI Shows Rising Price Performance With Jump To 92 RS Rating - Investor's Business Daily

Tempus exec-founded Pathos AI launched a $400M funding round. It's already filling up. - Crain's Chicago Business

Pathos AI gets AstraZeneca funding as biotech plans to raise up to $400M - Endpoints News

AI-Powered Imaging Diagnostics Market: Growth, Trends & - openPR.com

Finanzdaten der Tempus Ai Inc-Aktie (TEM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie TEM